Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy

Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy

Background: To investigate the diagnostic level of cystatin C and growth arrest-specific gene 6 (Gas6) levels in elderly type 2 diabetic patients with different degrees of diabetic nephropathy (DN). Methods: Four hundred and eighty-two old people, including 130 healthy controls, 130 normoalbuminuric...

Full description

Bibliographic Details
Main Authors:	Wenni Li, Junlin Wang, Lina Ge, Jiehui Shan, Chunbing Zhang, Jianping Liu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-05-01
Series:	Clinical and Experimental Hypertension
Subjects:	biomarker cystatin c diabetic nephropathy (dn) early detection growth arrest-specific gene 6 (gas6)
Online Access:	http://dx.doi.org/10.1080/10641963.2017.1288739

Similar Items

Urinary exosome proteins PAK6 and EGFR as noninvasive diagnostic biomarkers of diabetic nephropathy
by: Tao Li, et al.
Published: (2023-10-01)

Growth Arrest-Specific 6 (Gas6) and TAM Receptors in Mouse Platelets
by: Fikriye Uras, et al.
Published: (2015-02-01)

Growth arrest-specific 6 protein in HIV-infected patients: Determination of plasma level and different antiretroviral regimens
by: Te-Yu Lin, et al.
Published: (2021-10-01)

Growth arrest-specific 6 as a predictor of gastroesophageal varices in patients with liver cirrhosis
by: Khaled A.-A Eid, et al.
Published: (2021-01-01)

Epigenetics of Diabetic Nephropathy: From Biology to Therapeutics
by: Keith Al-Hasani, et al.
Published: (2020-03-01)

Multiple Regulatory Levels of Growth Arrest-Specific 6 in Mucosal Immunity Against an Oral Pathogen
by: Maria Nassar, et al.
Published: (2018-06-01)

Serum Homocysteine, cystatin C as Biomarkers for Progression of Diabetic Nephropathy
by: Xu Weihai, et al.
Published: (2019-12-01)

Comprehensive Diagnostics of Diabetic Nephropathy by Transcriptome RNA Sequencing
by: Lei L, et al.
Published: (2022-10-01)

Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy
by: Liu C, et al.
Published: (2022-08-01)

Comparison of Levels of Nephropathy Biomarkers in HIV-infected Individuals and Healthy Volunteers
by: Damla ERTÜRK, et al.
Published: (2023-01-01)

Utility of Serum Growth Arrest-Specific Protein 6 as a Biomarker of Severity and Prognosis After Severe Traumatic Brain Injury: A Prospective Observational Study
by: Ni BK, et al.
Published: (2022-07-01)

Correlation between serum homocysteine level and clinicopathological factors of IgA nephropathy
by: Cai Xiao-fan, et al.
Published: (2025-01-01)

Role of phosphor and GAS-6 in inflammation in hemodialysis patients in Tabriz, Iran
by: Jamal Halaj Zadeh, et al.
Published: (2014-02-01)

Targeting Gas6/TAM in cancer cells and tumor microenvironment
by: Guiling Wu, et al.
Published: (2018-01-01)

Role of methyltransferase like 3 regulating pri-miR-21 methylation in renal fibrosis of diabetes nephropathy
by: WU Jiajin, et al.
Published: (2023-01-01)

A novel homozygous variant in PADI6 is associate with human cleavage-stage embryonic arrest
by: Guangyi Cao, et al.
Published: (2023-08-01)

SIRT6’s function in controlling the metabolism of lipids and glucose in diabetic nephropathy
by: Ying Wang, et al.
Published: (2023-10-01)

LncRNA Dlx6os1 Accelerates Diabetic Nephropathy Progression by Epigenetically Repressing SOX6 via Recruiting EZH2
by: Yan-Xia Chen, et al.
Published: (2022-01-01)

Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6
by: Ke Geng, et al.
Published: (2017-11-01)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
by: Tadesse Asmamaw Dejenie, et al.
Published: (2023-04-01)

Cystatin C versus Creatinine as Early Stage Diabetic Nephropathy Marker
by: Atteaya Zaman , Amena Rahim , Muhammad Afzal , Abdul Khaliq Naveed
Published: (2018-06-01)

Study on indicators of diabetic nephropathy
by: A. Shilpa, et al.
Published: (2023-04-01)

Checkpoint for Considering Interleukin-6 as a Potential Target to Mitigate Secondary Brain Injury after Cardiac Arrest
by: Jung A Yoon, et al.
Published: (2024-07-01)

Relationship of Soluble Klotho and Early Stage of Diabetic Nephropathy: A Systematic Review and Meta-Analysis
by: Caihong Xin, et al.
Published: (2022-05-01)

Additive Impact of Interleukin 6 and Neuron Specific Enolase for Prognosis in Patients With Out-of-Hospital Cardiac Arrest – Experience From the HAnnover COoling REgistry
by: Muharrem Akin, et al.
Published: (2022-05-01)

Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy
by: Ruijing Zhang, et al.
Published: (2025-02-01)

Melatonin alleviates renal injury by activating mitophagy in diabetic nephropathy
by: Hanfen Tang, et al.
Published: (2022-08-01)

Ginsenoside Rb1 attenuates age-associated vascular impairment by modulating the Gas6 pathway
by: Shiye Ke, et al.
Published: (2021-01-01)

Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2/GPX4 pathway
by: Lingyu Du, et al.
Published: (2024-12-01)

Diagnostic value of serum cystatin C for diabetic nephropathy: a meta-analysis
by: Xueling Liao, et al.
Published: (2022-06-01)

Polymorphisms of C-reactive protein and growth arrest-specific gene 6 modulate ischemic stroke susceptibility through gene–gene interactions in Chinese Han population
by: Xiaofeng Li, et al.
Published: (2020-01-01)

Association of rs7903146 polymorphism in the TCF7L2 gene with diabetic nephropathy and decreased estimated GFR in an Arab population in southwest Iran
by: Ali Karimi Akhormeh, et al.
Published: (2018-10-01)

Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention
by: Lucia Barbieri, et al.
Published: (2022-02-01)

Cystatin-C and TGF-β levels in patients with diabetic nephropathy
by: Mumtaz Takir, et al.
Published: (2016-11-01)

Lncrna CASC11 aggravates diabetic nephropathy via targeting FoxO1
by: Zhang Yun, et al.
Published: (2023-01-01)

INTERLEUKIN-6 AND DIABETIC NEPHROPATHY: PATHOGENIC INTERCONNECTIONS, TARGETS FOR NEPHROPROTECTION
by: I. Yu. Pchelin, et al.
Published: (2017-12-01)

Angiotensinogen Gene M235T and T174M Polymorphisms in Diabetic Nephropathy in a Bangladeshi Population
by: Md. Mizanur Rahman, et al.
Published: (2022-12-01)

The Molecular Mechanism of Renal Tubulointerstitial Inflammation Promoting Diabetic Nephropathy
by: Xue R, et al.
Published: (2023-12-01)

Diagnostic accuracy of serum cystatin C for early recognition of contrast induced nephropathy in Western Indians undergoing cardiac catheterization
by: Anand N. Shukla, et al.
Published: (2017-05-01)

Role of Beta Trace Protein and Cystatin C as a Potential Biomarker for Early Detection of Type 2 Diabetic Nephropathy
by: Kamal AL-Deen Hussein Ali, et al.
Published: (2024-04-01)